Galderma stock pre-market at EUR 209.25: dermatology business

Published on 10/26/2026 at 08:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The company operates across injectable aesthetics, skincare and therapeutic dermatology. At Lang & Schwarz the stock trades pre-market at EUR 209.25 on October 26, 2026.

Business model and market context

Galderma describes its dermatology business in its April 22, 2026 release.
Germany's DAX provides the market context for October 26, 2026.
Galderma stock trades pre-market at EUR 209.25 at 8:15 a.m. CET at Lang & Schwarz on October 26, 2026.

Galderma, CH1335392721, Illustration mit AI erstellt.

Galderma earns revenue across injectable aesthetics, dermatological skincare and therapeutic dermatology, according to its April 22, 2026 investor-relations release. At 8:15 a.m. CET on October 26, 2026, Lang & Schwarz quoted the stock at EUR 209.25.

Pre-market trading conditions

The bid was EUR 206.70 and the ask was EUR 211.80, a spread of 2.44 percent, indicating thin pre-market trading. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Galderma stock.

Galderma and the German market

Galderma sells products and services in injectable aesthetics, dermatological skincare and therapeutic dermatology through its dermatology business. The German market context is provided by the DAX on October 26, 2026.

Market context: Market report DAX.

More news and analysis on Galderma stock